Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C S Coleman

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|February 17, 1998
Assay of mammalian ornithine decarboxylase activity using [14C]ornithineC S Coleman, A E Pegg
The Journal of Biological Chemistry|May 2, 1997
Proteasomal degradation of spermidine/spermine N1-acetyltransferase requires the carboxyl-terminal glutamic acid residuesC S Coleman, A E Pegg
The Biochemical Journal|August 4, 2001
Polyamine analogues inhibit the ubiquitination of spermidine/spermine N1-acetyltransferase and prevent its targeting to the proteasome for degradationC S Coleman, A E Pegg
Biochemical Society Transactions|December 1, 1990
Polyamine excretion from human cancer cellsC S Coleman, H M Wallace
Biochemical Society Transactions|December 1, 1990
Changes in polyamine acetylation in human cancer cellsH M Wallace, C S Coleman
Biochemistry|October 17, 1995
Role of the carboxyl terminal MATEE sequence of spermidine/spermine N1-acetyltransferase in the activity and stabilization by the polyamine analog N1,N12-bis(ethyl)spermineC S Coleman, H Huang, A E Pegg
The Biochemical Journal|June 15, 1996
Structure and critical residues at the active site of spermidine/spermine-N1-acetyltransferaseC S Coleman, H Huang, A E Pegg
The Journal of Biological Chemistry|November 25, 1993
Effect of mutations at active site residues on the activity of ornithine decarboxylase and its inhibition by active site-directed irreversible inhibitorsC S Coleman, B A Stanley, A E Pegg
Advances in Experimental Medicine and Biology|January 1, 1988
Polyamine recycling enzymes in human cancer cellsH M Wallace, M E Nuttall, C S Coleman
Biochemical Pharmacology|September 1, 1988
Status of reduced glutathione in the human hepatoma cell line, HEP G2S J Duthie, C S Coleman, M H Grant
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|February 17, 1998
Assay of mammalian ornithine decarboxylase activity using [14C]ornithineC S Coleman, A E Pegg
The Journal of Biological Chemistry|May 2, 1997
Proteasomal degradation of spermidine/spermine N1-acetyltransferase requires the carboxyl-terminal glutamic acid residuesC S Coleman, A E Pegg
The Biochemical Journal|August 4, 2001
Polyamine analogues inhibit the ubiquitination of spermidine/spermine N1-acetyltransferase and prevent its targeting to the proteasome for degradationC S Coleman, A E Pegg
Biochemical Society Transactions|December 1, 1990
Polyamine excretion from human cancer cellsC S Coleman, H M Wallace
Biochemical Society Transactions|December 1, 1990
Changes in polyamine acetylation in human cancer cellsH M Wallace, C S Coleman
Biochemistry|October 17, 1995
Role of the carboxyl terminal MATEE sequence of spermidine/spermine N1-acetyltransferase in the activity and stabilization by the polyamine analog N1,N12-bis(ethyl)spermineC S Coleman, H Huang, A E Pegg
The Biochemical Journal|June 15, 1996
Structure and critical residues at the active site of spermidine/spermine-N1-acetyltransferaseC S Coleman, H Huang, A E Pegg
The Journal of Biological Chemistry|November 25, 1993
Effect of mutations at active site residues on the activity of ornithine decarboxylase and its inhibition by active site-directed irreversible inhibitorsC S Coleman, B A Stanley, A E Pegg
Advances in Experimental Medicine and Biology|January 1, 1988
Polyamine recycling enzymes in human cancer cellsH M Wallace, M E Nuttall, C S Coleman
Biochemical Pharmacology|September 1, 1988
Status of reduced glutathione in the human hepatoma cell line, HEP G2S J Duthie, C S Coleman, M H Grant
Pageof 3